Curative

Employer-based health insurance with $0 copays/deductibles after baseline visit

Website: https://curative.com/

PUBLIC

Attribute Value
Company Name Curative
Tagline Employer-based health insurance with $0 copays/deductibles after baseline visit
Headquarters Austin, Texas, United States
Founded 2020
Stage Series B
Business Model B2B
Industry Insurtech
Technology AI / Machine Learning
Geography North America
Growth Profile Venture Scale
Founding Team Co-Founders (3+)
Funding Label $100M+ (total disclosed ~$150,000,000)

PUBLIC

Data Accuracy: GREEN -- URLs confirmed via company press release and primary domain.

Executive Summary

PUBLIC

Curative is an employer-sponsored health insurance plan that eliminates copays and deductibles for in-network care, a model that has secured it a $1.275 billion valuation and a $150 million Series B round [Business Wire, Dec 2025]. The company's attention stems from a radical bet on preventative care as a cost-containment lever, a proposition that has attracted over 165,000 covered lives and an expected $570 million in revenue for 2025 [LinkedIn News, 2025].

Founded in 2020 as a diagnostics company, Curative executed a rapid pivot, scaling from a sepsis-focused risk-sharing model to a national COVID-19 testing operation before launching its current insurance product in late 2022 [LinkedIn, 2026]. The core product is a single-premium plan with $0 out-of-pocket costs, contingent on members completing an annual Baseline Visit within 120 days of enrollment [curative.com/about-us]. This design aims to invert traditional insurance incentives by making comprehensive coverage the reward for early engagement.

CEO Fred Turner, a serial entrepreneur who previously founded a diagnostics company and a genomic testing firm for cattle, leads the founding team [Forbes, 2017]. The company's financial backing is anchored by early investor Justin Mateen, whose position has reportedly compounded more than 400-fold, signaling deep insider conviction [Business Wire, Dec 2025]. The immediate strategic focus is on geographic expansion within Texas, Florida, and Georgia, supported by the new capital.

Over the next 12-18 months, the key watchpoints will be the sustainability of the $0 out-of-pocket model at scale, the rate of member compliance with the preventative visit requirement, and the execution of its national rollout against established insurance incumbents.

Data Accuracy: YELLOW -- Key metrics (members, revenue) are company-sourced via a single secondary report; valuation and funding are confirmed by primary press release.

Taxonomy Snapshot

Axis Value
Stage Series B
Business Model B2B
Industry / Vertical Insurtech
Technology Type AI / Machine Learning
Geography North America
Growth Profile Venture Scale
Founding Team Co-Founders (3+)
Funding $100M+

Company Overview

PUBLIC

Curative was founded in Austin, Texas in January 2020, initially as a diagnostics company focused on sepsis detection [Wikipedia]. The founding team, comprising Fred Turner, Isaac Turner, and Vlad Slepnev, built the company on a risk-sharing model with hospitals before a rapid pivot to COVID-19 testing in the same year [LinkedIn, 2026]. This pivot saw the organization scale from 7 to 7,000 employees in 12 months, administering an estimated 35 million tests, which provided the operational scale and capital base for its subsequent strategic shift [LinkedIn, 2026].

In the fall of 2022, the company executed a second pivot, launching its core business as Curative Insurance Company, an employer-based health insurer [LinkedIn, 2026]. Key milestones since the pivot include the launch of its $0 out-of-pocket health plan in select Texas markets, subsequent expansion into Florida and Georgia, and the announcement of a $150 million Series B funding round in December 2025 that established a $1.275 billion valuation [Business Wire, Dec 2025]. The company reports it now covers 165,000 people and expects $570 million in revenue for 2025 [LinkedIn News, 2025].

Data Accuracy: YELLOW -- Core founding details and the pivot timeline are sourced from a single LinkedIn post by a company executive, corroborated by secondary news reports. The 2025 revenue and member figures are company-reported via a single LinkedIn News article.

Product and Technology

MIXED

Curative’s product is a health insurance plan for self-funded employers, built around a single, conditional promise: members pay nothing out-of-pocket for in-network care after completing an annual preventative exam. The company’s public materials describe a plan with “$0 copays, $0 deductibles, and $0 out-of-pocket costs” for covered services, provided the member completes a Baseline Visit within 120 days of enrollment [Curative]. This visit, which the company reports 98% of members complete within the timeframe, serves as the primary engagement mechanism and underwriting filter [Healthcare Brew, Mar 2026]. The model is presented as a single monthly premium to employers, aiming to replace the complexity of traditional deductible and coinsurance structures with predictable, upfront pricing.

The operational wedge relies on steering engaged members toward a curated, in-network provider panel. Curative cites an “AI-powered member experience” as a core component of this guidance, though public details on the specific AI applications are limited to high-level descriptions of personalized care navigation and support [Business Wire, Dec 2025]. The technology stack appears oriented around member onboarding, provider network management, and claims adjudication, with inferences from historical job postings pointing to backend systems built on modern cloud infrastructure. The product is currently available to employers with 51 or more employees in select regions of Texas, Florida, and Georgia [Business Wire, Dec 2025].

Data Accuracy: YELLOW -- Core product claims are from the company website and press releases; the 98% completion rate is from a single trade publication report. AI capabilities and tech stack details are not independently verified.

Market Research

PUBLIC The market for employer-sponsored health insurance is undergoing a fundamental shift, driven by escalating costs and employee dissatisfaction with opaque, complex benefit structures. This creates a tangible opening for new entrants promising simplicity and cost control.

Third-party market sizing for Curative's specific niche,employer-based plans with a $0 out-of-pocket design,is not publicly available. However, the broader context is well-documented. The U.S. employer-sponsored insurance market covers approximately 158 million people and represents a total premium volume exceeding $1 trillion annually [KFF, 2024]. The segment for self-funded employers, a key target for Curative's model, accounts for roughly 65% of covered workers at firms with 200 or more employees [KFF, 2024]. This serves as an analogous market size, indicating the substantial pool of potential premium dollars and member lives.

Demand drivers are clear and cited across industry reports. Employer health benefit costs are projected to rise by over 6% annually, outpacing general inflation and putting significant pressure on corporate budgets [PwC, 2025]. Concurrently, employee frustration is high, with surveys indicating that complexity, surprise bills, and high deductibles are primary pain points [J.D. Power, 2025]. These twin pressures create a receptive environment for solutions that promise predictable costs for the employer and a simplified, engaging experience for the employee.

Adjacent and substitute markets include the direct-to-consumer health plan market, which remains small, and the growing market for healthcare navigation and advocacy services. The regulatory environment is a critical macro force. Curative operates as a licensed insurance company, subject to state-by-state insurance department approvals, network adequacy rules, and rate filings. Expansion into new states is therefore a capital- and time-intensive process, not merely a sales motion. Federal policy around the Affordable Care Act and regulations governing self-funded plans also shape the landscape.

Metric Value
Total Employer-Sponsored Market 158 million people
Self-Funded Segment (Large Firms) 103 million people (estimated)

The chart illustrates the scale of the incumbent market. The takeaway is that Curative's addressable market, even within its initial three-state footprint, is measured in tens of billions of dollars in premium, providing a long runway for growth if the unit economics prove sustainable.

Data Accuracy: GREEN -- Market size figures corroborated by KFF and PwC industry reports.

Competitive Landscape

MIXED Curative competes by replacing the traditional employer health plan with a single, simple, and expensive-sounding promise: $0 out-of-pocket costs for all in-network care, conditioned on a single preventative visit.

Company Positioning Stage / Funding Notable Differentiator Source
Curative Employer-based insurance with $0 copays/deductibles after a baseline visit. Series B, $150M raised (2025), $1.275B valuation. Condition-based $0 OOP model; AI-powered member guidance; rapid pivot from diagnostics. [Business Wire, Dec 2025]
Centivo Health plan for self-funded employers focused on affordability via primary care. Venture-backed, ~$140M total funding. Built around an accountable primary care network to lower costs; targets employers of all sizes. [Crunchbase]
Sana Benefits Simplified health plans for small to midsize businesses. Series B, $60M raised (2024). Focus on sub-250 employee market; emphasis on transparent pricing and customer service. [Crunchbase]

The competitive map for employer-sponsored insurance is stratified by employer size and funding model. Curative’s initial target of employers with 51+ employees in Texas, Florida, and Georgia [Wikipedia] places it in direct competition with regional carriers and third-party administrators (TPAs) that serve the mid-market. Its most direct challengers are other venture-backed insurtechs like Centivo and Sana, which also promise simplicity and cost control but through different mechanisms. Centivo’s wedge is an integrated primary care network designed to manage costs upstream, while Sana focuses on administrative simplicity for smaller employers. The broader incumbent field includes national carriers (UnitedHealth, Aetna/CVS), Blue Cross Blue Shield affiliates in each state, and a dense ecosystem of TPAs and benefit consultants who broker plans. Adjacent substitutes include direct primary care (DPC) memberships bundled with high-deductible plans, and health reimbursement arrangements (HRAs) that give employers more defined contribution control.

Curative’s defensible edge today is its product design and branding, not its network or scale. The $0 OOP promise, contingent on a baseline visit, is a starkly simple marketing message that cuts through the complexity of deductibles and coinsurance. Early traction of 165,000 covered lives and an expected $570 million in revenue for 2025 [LinkedIn News, 2025] suggests the message resonates with some employer buyers. The company’s AI-powered member experience, cited in its funding announcement [Business Wire, Dec 2025], is positioned as a tool to ensure compliance and steer members to high-value, in-network care, potentially creating a data feedback loop. However, this edge is perishable. The product concept is not patent-protected and could be replicated by a carrier with a larger network and brand trust, albeit likely with less focus. The more durable advantage may be in execution speed and capital, evidenced by its recent $150 million Series B, which provides runway to expand geographically and invest in member engagement before incumbents can organize a competitive response.

The company’s most significant exposure is its limited geographic and provider network. Operating in select regions of three states [Business Wire, Dec 2025] is a major constraint for multi-state employers, a segment dominated by national carriers and large TPAs. Curative does not own its provider network; it contracts with one, which means its cost structure and member experience are dependent on third-party negotiations and performance. This contrasts with vertically integrated models like Kaiser Permanente or newer primary-care-centric plans. Furthermore, its model is untested in higher-cost, more regulated northern states or in the small-group (under 50 lives) market, where Sana has built a presence. A named competitor’s specific advantage is Centivo’s focus on an owned, accountable primary care network, which could provide a more clinically integrated and potentially lower-cost pathway than Curative’s visit-contingent model.

The most plausible 18-month scenario is one of segmented coexistence and regional expansion. If Curative can consistently demonstrate that its baseline visit requirement drives higher preventative care utilization and lowers downstream specialty and emergency costs, it will win employer accounts in the 100-5,000 life range within its operating states, particularly those frustrated with opaque carrier renewals. The loser in this scenario would be the traditional regional carrier or TPA that fails to offer a simplified, engagement-focused alternative and continues to rely solely on network discounts and opaque rebates. If, however, medical cost trends outpace premium growth or if member adherence to the care guidance falters, Curative’s model could face adverse selection, making it a niche player for the health-conscious, while a competitor like Centivo, with its clinical integration, gains broader employer adoption for its perceived actuarial soundness.

Data Accuracy: YELLOW -- Competitor profiles and Curative's positioning are confirmed by public sources; detailed funding for competitors is from Crunchbase without independent primary source verification for this report.

Opportunity

PUBLIC

If Curative's model of zero out-of-pocket costs for engaged members scales nationally, the company could capture a multi-billion dollar share of the $1.4 trillion employer-sponsored health insurance market by fundamentally realigning the incentives of a payer.

The headline opportunity for Curative is to become the default health plan for self-funded mid-market employers seeking to control costs while attracting talent. The company's $0 copay, $0 deductible structure is a powerful differentiator in a market where high-deductible plans have become the norm. The cited evidence suggests this outcome is reachable, not merely aspirational, because the model has already demonstrated initial traction with 165,000 covered lives and a projected $570 million in revenue for 2025 [LinkedIn News, 2025]. The recent $150 million Series B, which valued the company at $1.275 billion, provides the capital runway to test national expansion [Business Wire, Dec 2025]. The core bet is that by mandating and facilitating a preventive Baseline Visit, Curative can identify and manage health risks earlier than traditional insurers, theoretically lowering long-term medical costs enough to fund the zero out-of-pocket promise.

Growth will likely follow one of several concrete paths, each with identifiable catalysts.

Scenario What happens Catalyst Why it's plausible
State-by-State Regulatory Domino Curative methodically enters new states, replicating its Texas, Florida, and Georgia footprint to achieve a true national footprint for employers with multi-state workforces. Securing a key partnership with a national brokerage or benefits administrator to streamline distribution. The company has already proven its ability to launch and operate in three distinct regulatory environments [Business Wire, Dec 2025]. The model's appeal to employers is clear, creating demand pull from brokers.
Mid-Market Land-and-Expand The company achieves deep penetration within its core 51+ employee segment, using high member satisfaction and demonstrable cost savings to expand within existing employer accounts and attract peer companies. Publication of an independently verified study showing lower total cost of care or higher member engagement versus traditional plans. Early traction of 165,000 members suggests product-market fit within the initial target segment [LinkedIn News, 2025]. The model's simplicity is a strong sales tool for HR departments.

Compounding for Curative looks like a data-driven underwriting flywheel. Each new member who completes the Baseline Visit generates a standardized health dataset. As membership scales, this aggregated data could improve the company's ability to predict risk, refine its provider network for value, and optimize care navigation. The company cites an "AI-powered member experience" as a core investment area, suggesting the beginnings of this feedback loop [Business Wire, Dec 2025]. If successful, better risk prediction translates to more accurate pricing and sustainable margins, which in turn funds further investment in member benefits and network quality, attracting more employers. The requirement of the Baseline Visit acts as a filter, ensuring the enrolled population is actively engaged from day one, which is the foundational premise for the entire economic model.

The size of the win can be framed by looking at a comparable public entity. Centene, a large managed care organization that also focuses on government-sponsored and complex populations, had a market capitalization of approximately $38 billion as of early 2026. While Curative's model is distinct, it operates in the same vast employer-sponsored insurance pool. If Curative's scenario of becoming a dominant, national mid-market player plays out, capturing even a single-digit percentage of that market could support a valuation meaningfully above its current $1.275 billion unicorn status. This is a scenario-based outcome, not a forecast, but it illustrates the magnitude of the opportunity if the model proves scalable and sustainable.

Data Accuracy: YELLOW -- Growth scenarios and compounding mechanics are inferred from the company's stated model and early traction metrics, which are sourced from a single secondary report. The comparable market cap is a contemporaneous public figure.

Sources

PUBLIC

  1. [Business Wire, Dec 2025] Curative Raises $150 Million in Series B Funding to Redefine the Future of Health Insurance | https://www.businesswire.com/news/home/20251202857803/en/Curative-Raises-$150-Million-in-Series-B-Funding-to-Redefine-the-Future-of-Health-Insurance

  2. [LinkedIn News, 2025] Health insurance startup Curative raises $150M | https://www.linkedin.com/news/story/health-insurance-startup-curative-raises-150m-6787620/

  3. [Wikipedia] Curative (company) | https://en.wikipedia.org/wiki/Curative_(company)

  4. [LinkedIn, 2026] Hasan Kavak - Curative | LinkedIn | https://www.linkedin.com/in/hasankavak/

  5. [Curative] About Our Health Care | Curative | https://curative.com/about-us

  6. [Healthcare Brew, Mar 2026] Curative CEO Fred Turner explains why his alternative health plan is valued at $1.3b | https://www.healthcare-brew.com/stories/2026/03/20/curative-ceo-fred-turner-alternative-health-plan

  7. [Forbes, 2017] TL Biolabs | https://www.forbes.com/profile/tl-biolabs/

  8. [KFF, 2024] Employer Health Benefits Survey | https://www.kff.org/report-section/ehbs-2024-summary-of-findings/

  9. [PwC, 2025] Medical Cost Trend: Behind the Numbers 2025 | https://www.pwc.com/us/en/industries/health-industries/library/behind-the-numbers.html

  10. [J.D. Power, 2025] U.S. Commercial Member Health Plan Study | https://www.jdpower.com/business/press-releases/2025-us-commercial-member-health-plan-study

  11. [Crunchbase] Centivo | https://www.crunchbase.com/organization/centivo

  12. [Crunchbase] Sana Benefits | https://www.crunchbase.com/organization/sana-benefits

Articles about Curative

View on Startuply.vc